Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Stimulating Factor

David A. Hess, Jesper Bonde, Timothy C. Craft, Louisa Wirthlin, Sarah Hohm, Ryan Lahey, Laura M. Todt, John F. Dipersio, Steven M. Devine, Jan Nolta

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

AMD3100 inhibits the interaction between SDF-1 and CXCR4, and rapidly mobilizes hematopoietic progenitors for clinical transplantation. However, the repopulating function of human cells mobilized with AMD3100 has not been characterized in comparison to cells mobilized with granulocyte-colony stimulating factor (G-CSF) in the same donor. Therefore, healthy donors were leukapheresed 4 hours after injection with AMD3100; after 10 days of drug clearance the same donor was mobilized with G-CSF, allowing a paired comparison of repopulation by mobilized cells. Transplantation of mononuclear cells (MNC) or purified CD34+ cells was compared at limiting dilution into NOD/SCID mice. Human AMD3100-mobilized MNC possessed enhanced repopulating frequency in comparison to G-CSF-mobilized MNC from paired donors, and purified CD34+ progenitors were at least as efficient as the G-CSF mobilized cells. The frequencies of NOD/SCID repopulating cells (SRC) were 1 SRC in 8.7 × 106 AMD3100-mobilized MNC compared to 1 SRC in 29.0 × 106 G-CSF-mobilized MNC, and 1 SRC in 1.2 × 105 AMD3100-mobilized CD34+ cells compared to 1 SRC in 1.8 × 105 G-CSF-mobilized CD34+ cells. Hematopoietic differentiation of transplanted progenitors was similar after AMD3100 or G-CSF-mobilization. Thus, AMD3100 mobilized peripheral blood represents a rapidly obtained, highly repopulating source of hematopoietic progenitors for clinical transplantation.

Original languageEnglish (US)
Pages (from-to)398-411
Number of pages14
JournalBiology of Blood and Marrow Transplantation
Volume13
Issue number4
DOIs
StatePublished - Apr 2007
Externally publishedYes

Fingerprint

Inbred NOD Mouse
SCID Mice
Granulocyte Colony-Stimulating Factor
Stem Cells
JM 3100
Transplantation
Matched-Pair Analysis
Cell Transplantation

Keywords

  • AMD3100
  • CD34
  • GCSF
  • hematopoiesis
  • NOD/SCID transplantation
  • Stem cell mobilization

ASJC Scopus subject areas

  • Transplantation

Cite this

Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Stimulating Factor. / Hess, David A.; Bonde, Jesper; Craft, Timothy C.; Wirthlin, Louisa; Hohm, Sarah; Lahey, Ryan; Todt, Laura M.; Dipersio, John F.; Devine, Steven M.; Nolta, Jan.

In: Biology of Blood and Marrow Transplantation, Vol. 13, No. 4, 04.2007, p. 398-411.

Research output: Contribution to journalArticle

Hess, David A. ; Bonde, Jesper ; Craft, Timothy C. ; Wirthlin, Louisa ; Hohm, Sarah ; Lahey, Ryan ; Todt, Laura M. ; Dipersio, John F. ; Devine, Steven M. ; Nolta, Jan. / Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Stimulating Factor. In: Biology of Blood and Marrow Transplantation. 2007 ; Vol. 13, No. 4. pp. 398-411.
@article{9f9870a40b1d4b308ee36470111ac8bb,
title = "Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Stimulating Factor",
abstract = "AMD3100 inhibits the interaction between SDF-1 and CXCR4, and rapidly mobilizes hematopoietic progenitors for clinical transplantation. However, the repopulating function of human cells mobilized with AMD3100 has not been characterized in comparison to cells mobilized with granulocyte-colony stimulating factor (G-CSF) in the same donor. Therefore, healthy donors were leukapheresed 4 hours after injection with AMD3100; after 10 days of drug clearance the same donor was mobilized with G-CSF, allowing a paired comparison of repopulation by mobilized cells. Transplantation of mononuclear cells (MNC) or purified CD34+ cells was compared at limiting dilution into NOD/SCID mice. Human AMD3100-mobilized MNC possessed enhanced repopulating frequency in comparison to G-CSF-mobilized MNC from paired donors, and purified CD34+ progenitors were at least as efficient as the G-CSF mobilized cells. The frequencies of NOD/SCID repopulating cells (SRC) were 1 SRC in 8.7 × 106 AMD3100-mobilized MNC compared to 1 SRC in 29.0 × 106 G-CSF-mobilized MNC, and 1 SRC in 1.2 × 105 AMD3100-mobilized CD34+ cells compared to 1 SRC in 1.8 × 105 G-CSF-mobilized CD34+ cells. Hematopoietic differentiation of transplanted progenitors was similar after AMD3100 or G-CSF-mobilization. Thus, AMD3100 mobilized peripheral blood represents a rapidly obtained, highly repopulating source of hematopoietic progenitors for clinical transplantation.",
keywords = "AMD3100, CD34, GCSF, hematopoiesis, NOD/SCID transplantation, Stem cell mobilization",
author = "Hess, {David A.} and Jesper Bonde and Craft, {Timothy C.} and Louisa Wirthlin and Sarah Hohm and Ryan Lahey and Todt, {Laura M.} and Dipersio, {John F.} and Devine, {Steven M.} and Jan Nolta",
year = "2007",
month = "4",
doi = "10.1016/j.bbmt.2006.12.445",
language = "English (US)",
volume = "13",
pages = "398--411",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Human Progenitor Cells Rapidly Mobilized by AMD3100 Repopulate NOD/SCID Mice with Increased Frequency in Comparison to Cells from the Same Donor Mobilized by Granulocyte Colony Stimulating Factor

AU - Hess, David A.

AU - Bonde, Jesper

AU - Craft, Timothy C.

AU - Wirthlin, Louisa

AU - Hohm, Sarah

AU - Lahey, Ryan

AU - Todt, Laura M.

AU - Dipersio, John F.

AU - Devine, Steven M.

AU - Nolta, Jan

PY - 2007/4

Y1 - 2007/4

N2 - AMD3100 inhibits the interaction between SDF-1 and CXCR4, and rapidly mobilizes hematopoietic progenitors for clinical transplantation. However, the repopulating function of human cells mobilized with AMD3100 has not been characterized in comparison to cells mobilized with granulocyte-colony stimulating factor (G-CSF) in the same donor. Therefore, healthy donors were leukapheresed 4 hours after injection with AMD3100; after 10 days of drug clearance the same donor was mobilized with G-CSF, allowing a paired comparison of repopulation by mobilized cells. Transplantation of mononuclear cells (MNC) or purified CD34+ cells was compared at limiting dilution into NOD/SCID mice. Human AMD3100-mobilized MNC possessed enhanced repopulating frequency in comparison to G-CSF-mobilized MNC from paired donors, and purified CD34+ progenitors were at least as efficient as the G-CSF mobilized cells. The frequencies of NOD/SCID repopulating cells (SRC) were 1 SRC in 8.7 × 106 AMD3100-mobilized MNC compared to 1 SRC in 29.0 × 106 G-CSF-mobilized MNC, and 1 SRC in 1.2 × 105 AMD3100-mobilized CD34+ cells compared to 1 SRC in 1.8 × 105 G-CSF-mobilized CD34+ cells. Hematopoietic differentiation of transplanted progenitors was similar after AMD3100 or G-CSF-mobilization. Thus, AMD3100 mobilized peripheral blood represents a rapidly obtained, highly repopulating source of hematopoietic progenitors for clinical transplantation.

AB - AMD3100 inhibits the interaction between SDF-1 and CXCR4, and rapidly mobilizes hematopoietic progenitors for clinical transplantation. However, the repopulating function of human cells mobilized with AMD3100 has not been characterized in comparison to cells mobilized with granulocyte-colony stimulating factor (G-CSF) in the same donor. Therefore, healthy donors were leukapheresed 4 hours after injection with AMD3100; after 10 days of drug clearance the same donor was mobilized with G-CSF, allowing a paired comparison of repopulation by mobilized cells. Transplantation of mononuclear cells (MNC) or purified CD34+ cells was compared at limiting dilution into NOD/SCID mice. Human AMD3100-mobilized MNC possessed enhanced repopulating frequency in comparison to G-CSF-mobilized MNC from paired donors, and purified CD34+ progenitors were at least as efficient as the G-CSF mobilized cells. The frequencies of NOD/SCID repopulating cells (SRC) were 1 SRC in 8.7 × 106 AMD3100-mobilized MNC compared to 1 SRC in 29.0 × 106 G-CSF-mobilized MNC, and 1 SRC in 1.2 × 105 AMD3100-mobilized CD34+ cells compared to 1 SRC in 1.8 × 105 G-CSF-mobilized CD34+ cells. Hematopoietic differentiation of transplanted progenitors was similar after AMD3100 or G-CSF-mobilization. Thus, AMD3100 mobilized peripheral blood represents a rapidly obtained, highly repopulating source of hematopoietic progenitors for clinical transplantation.

KW - AMD3100

KW - CD34

KW - GCSF

KW - hematopoiesis

KW - NOD/SCID transplantation

KW - Stem cell mobilization

UR - http://www.scopus.com/inward/record.url?scp=33947245648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947245648&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2006.12.445

DO - 10.1016/j.bbmt.2006.12.445

M3 - Article

VL - 13

SP - 398

EP - 411

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 4

ER -